Active transcutaneous bone conduction implant: Middle fossa placement technique in children with bilateral microtia and external auditory canal atresia

Carolina Der, Sofía Bravo-Torres, Nicolás Pons

Resultado de la investigación: Article

Resumen

Aim: The aim of this study is to present the middle fossa technique (MFT) as an alternative for patients who cannot undergo traditional surgery for active transcutaneous bone conduction implants (ATBCI) due to their altered anatomy or desire for future aesthetic reconstruction. Design: A case series descriptive study was designed. The MFT was developed. Preoperative and postoperative information from 24 patients with external auditory canal atresia (EACA) and implanted with ATBCI was reviewed. Results: A total of 24 children with bilateral EACA received implants in the middle cranial fossa. Their average age was 12. Of these patients, eight had an associated congenital disorder: Goldenhar Syndrome, Treacher Collins Syndrome or the Pierre Robin Sequence. The average follow-up was at 17 months (ranging from between 2- and 36 mo) and there were no major complications. Four patients showed skin erythema at the processor site after turn on, which was solved by lowering the magnet strength. One patient had a scalp hematoma that required puncture drainage. The hearing thresholds went down on average from 66.5 to 25.2 dB 1 month after turn on. Speech recognition improved respectively from 29.4% without and 78.9% with a bone conduction hearing aid to 96.4%. Conclusion: MFT placement of the ATBCI was proven to be safe and effective and a viable option for treating pediatric patients with EACA who cannot receive implants at the sinodural angle or in the retrosigmoidal position because of their altered anatomy and/or desire for future aesthetic reconstruction.

IdiomaEnglish
Páginase342-e348
PublicaciónOtology and Neurotology
Volumen39
Número de edición5
DOI
EstadoPublished - 1 jun 2018

Huella dactilar

Bone Conduction
Ear Canal
Esthetics
Anatomy
Mandibulofacial Dysostosis
Pierre Robin Syndrome
Goldenhar Syndrome
Middle Cranial Fossa
Paracentesis
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hearing Aids
Magnets
Erythema
Scalp
Hematoma
Hearing
Congenital Microtia
Pediatrics
Skin

Keywords

    ASJC Scopus subject areas

    • Otorhinolaryngology
    • Sensory Systems
    • Clinical Neurology

    Citar esto

    @article{9dd93ea25cca4d99affd763e8d9b8d4b,
    title = "Active transcutaneous bone conduction implant: Middle fossa placement technique in children with bilateral microtia and external auditory canal atresia",
    abstract = "Aim: The aim of this study is to present the middle fossa technique (MFT) as an alternative for patients who cannot undergo traditional surgery for active transcutaneous bone conduction implants (ATBCI) due to their altered anatomy or desire for future aesthetic reconstruction. Design: A case series descriptive study was designed. The MFT was developed. Preoperative and postoperative information from 24 patients with external auditory canal atresia (EACA) and implanted with ATBCI was reviewed. Results: A total of 24 children with bilateral EACA received implants in the middle cranial fossa. Their average age was 12. Of these patients, eight had an associated congenital disorder: Goldenhar Syndrome, Treacher Collins Syndrome or the Pierre Robin Sequence. The average follow-up was at 17 months (ranging from between 2- and 36 mo) and there were no major complications. Four patients showed skin erythema at the processor site after turn on, which was solved by lowering the magnet strength. One patient had a scalp hematoma that required puncture drainage. The hearing thresholds went down on average from 66.5 to 25.2 dB 1 month after turn on. Speech recognition improved respectively from 29.4{\%} without and 78.9{\%} with a bone conduction hearing aid to 96.4{\%}. Conclusion: MFT placement of the ATBCI was proven to be safe and effective and a viable option for treating pediatric patients with EACA who cannot receive implants at the sinodural angle or in the retrosigmoidal position because of their altered anatomy and/or desire for future aesthetic reconstruction.",
    keywords = "Active transcutaneous bone conduction implant, External auditory canal atresia, Microtia, Middle fossa technique",
    author = "Carolina Der and Sof{\'i}a Bravo-Torres and Nicol{\'a}s Pons",
    year = "2018",
    month = "6",
    day = "1",
    doi = "10.1097/MAO.0000000000001809",
    language = "English",
    volume = "39",
    pages = "e342--e348",
    journal = "Otology and Neurotology",
    issn = "1531-7129",
    publisher = "Lippincott Williams and Wilkins",
    number = "5",

    }

    Active transcutaneous bone conduction implant : Middle fossa placement technique in children with bilateral microtia and external auditory canal atresia. / Der, Carolina; Bravo-Torres, Sofía; Pons, Nicolás.

    En: Otology and Neurotology, Vol. 39, N.º 5, 01.06.2018, p. e342-e348.

    Resultado de la investigación: Article

    TY - JOUR

    T1 - Active transcutaneous bone conduction implant

    T2 - Otology and Neurotology

    AU - Der, Carolina

    AU - Bravo-Torres, Sofía

    AU - Pons, Nicolás

    PY - 2018/6/1

    Y1 - 2018/6/1

    N2 - Aim: The aim of this study is to present the middle fossa technique (MFT) as an alternative for patients who cannot undergo traditional surgery for active transcutaneous bone conduction implants (ATBCI) due to their altered anatomy or desire for future aesthetic reconstruction. Design: A case series descriptive study was designed. The MFT was developed. Preoperative and postoperative information from 24 patients with external auditory canal atresia (EACA) and implanted with ATBCI was reviewed. Results: A total of 24 children with bilateral EACA received implants in the middle cranial fossa. Their average age was 12. Of these patients, eight had an associated congenital disorder: Goldenhar Syndrome, Treacher Collins Syndrome or the Pierre Robin Sequence. The average follow-up was at 17 months (ranging from between 2- and 36 mo) and there were no major complications. Four patients showed skin erythema at the processor site after turn on, which was solved by lowering the magnet strength. One patient had a scalp hematoma that required puncture drainage. The hearing thresholds went down on average from 66.5 to 25.2 dB 1 month after turn on. Speech recognition improved respectively from 29.4% without and 78.9% with a bone conduction hearing aid to 96.4%. Conclusion: MFT placement of the ATBCI was proven to be safe and effective and a viable option for treating pediatric patients with EACA who cannot receive implants at the sinodural angle or in the retrosigmoidal position because of their altered anatomy and/or desire for future aesthetic reconstruction.

    AB - Aim: The aim of this study is to present the middle fossa technique (MFT) as an alternative for patients who cannot undergo traditional surgery for active transcutaneous bone conduction implants (ATBCI) due to their altered anatomy or desire for future aesthetic reconstruction. Design: A case series descriptive study was designed. The MFT was developed. Preoperative and postoperative information from 24 patients with external auditory canal atresia (EACA) and implanted with ATBCI was reviewed. Results: A total of 24 children with bilateral EACA received implants in the middle cranial fossa. Their average age was 12. Of these patients, eight had an associated congenital disorder: Goldenhar Syndrome, Treacher Collins Syndrome or the Pierre Robin Sequence. The average follow-up was at 17 months (ranging from between 2- and 36 mo) and there were no major complications. Four patients showed skin erythema at the processor site after turn on, which was solved by lowering the magnet strength. One patient had a scalp hematoma that required puncture drainage. The hearing thresholds went down on average from 66.5 to 25.2 dB 1 month after turn on. Speech recognition improved respectively from 29.4% without and 78.9% with a bone conduction hearing aid to 96.4%. Conclusion: MFT placement of the ATBCI was proven to be safe and effective and a viable option for treating pediatric patients with EACA who cannot receive implants at the sinodural angle or in the retrosigmoidal position because of their altered anatomy and/or desire for future aesthetic reconstruction.

    KW - Active transcutaneous bone conduction implant

    KW - External auditory canal atresia

    KW - Microtia

    KW - Middle fossa technique

    UR - http://www.scopus.com/inward/record.url?scp=85048126005&partnerID=8YFLogxK

    U2 - 10.1097/MAO.0000000000001809

    DO - 10.1097/MAO.0000000000001809

    M3 - Article

    VL - 39

    SP - e342-e348

    JO - Otology and Neurotology

    JF - Otology and Neurotology

    SN - 1531-7129

    IS - 5

    ER -